Lisata Therapeutics, Inc.
At Close: 4:00 PM
LSTA Stock Price Graph
LSTA Stock Price Today
Lisata Therapeutics, Inc. (LSTA) stock declined over -0.82% intraday to trade at $2.41 a share on NASDAQ. The stock opened with a loss of -14.46% at $2.07 and touched an intraday high of $2.13, falling -0.41% against the last close of $2.42. The Lisata Therapeutics, Inc. in stock market went to a low of $2.02 during the session.
LSTA Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
LSTA Stock Price History Chart
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Frequently Asked Questions
What is the current Lisata Therapeutics, Inc. (LSTA) stock price?
Lisata Therapeutics, Inc. (NASDAQ: LSTA) stock price is $2.41 in the last trading session. During the trading session, LSTA stock reached the peak price of $2.13 while $2.02 was the lowest point it dropped to. The percentage change in LSTA stock occurred in the recent session was -0.82% while the dollar amount for the price change in LSTA stock was -$0.02.
LSTA's industry and sector of operation?
The NASDAQ listed LSTA is part of Biotechnology industry that operates in the broader Healthcare sector. Lisata Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue.
Who are the executives of LSTA?
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
Chief Executive Officer & Director
Mr. James Nisco
Vice President of Fin. & Treasury
Dr. Kristen K. Buck M.D.
Executive Vice President of R&D and Chief Medical Officer
Ms. Gail Holler
Vice President of HR
How LSTA did perform over past 52-week?
LSTA's closing price is 0.34% higher than its 52-week low of $1.95 where as its distance from 52-week high of $4.58 is -0.67%.
How many employees does LSTA have?
Number of LSTA employees currently stands at N/A. LSTA operates from 110 Allen Road, Basking Ridge, NJ 07920, US.
Link for LSTA official website?
Official Website of LSTA is: https://www.lisata.com
How do I contact LSTA?
How many shares of LSTA are traded daily?
LSTA stock volume for the day was 24600.00 shares. The average number of LSTA shares traded daily for last 3 months was 21.52 Thousands.
What is the market cap of LSTA currently?
The market value of LSTA currently stands at $20.27 Million with its latest stock price at $2.41 and N/A of its shares outstanding.